Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ravali Veeramachaneni"'
Autor:
Ravali Veeramachaneni, Alexander White-Cotsmire, Paige Norwick, Olga Demidova, Arlene Roseberg, Juan P del Rincon
Publikováno v:
Journal of the Endocrine Society. 6:A775-A776
Background Nodular myxedema is an uncommon skin manifestation of autoimmune thyroid disease. Almost always associated with significant orbitopathy from the deposition of glycosaminoglycans by stimulated fibroblasts. Clinical Case A 57-year-old male p
Publikováno v:
Journal of the Endocrine Society. 6:A781-A782
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in a pandemic in 2019, causing systemic complications including endocrine system diseases. Subacute thyro
Publikováno v:
Journal of the Endocrine Society. 6:A320-A320
Background The COVID-19 pandemic led to crisis-level shortage of hospital beds and staff, predominantly in the ICUs. Minimization of patient contact moved the FDA to issue a statement that allowed CGMs in hospitals, which were quickly adopted by ICUs
Autor:
Anum Khan, Swetha Paduri, Amna Elahi, Sabah Patel, Raghda A Anbari, Ravali Veeramachaneni, Mahwash Siddiqui, Karen Carvajal, Isha Shrestha, Charles Barsano
Publikováno v:
Journal of the Endocrine Society. 6:A788-A788
The thyroid nodule ultrasonic characteristic referred to as "Taller-than-Wide" (TtW) is defined as a nodule's anterior-posterior diameter/left-right diameter ratio (i. e. AP/LR ratio) on transverse view. This characteristic is regarded as a major fea
Publikováno v:
Journal of the Endocrine Society. 6:A785-A785
Background Thyroid storm is an endocrinological emergency caused by severe thyrotoxicosis. COVID-19, caused by the novel coronavirus SARS-CoV-2, is known to cause thyroid-related complications of subacute thyroiditis but the occurrence of thyroid sto
Publikováno v:
Journal of the Endocrine Society
Hypercalcemia (HC) is a common clinical problem. Among all causes of HC, primary hyperparathyroidism (HPT) and malignancy are the most common, accounting for >90 % of cases. We present a case of HC in a patient attributed to long-standing history of
Autor:
Ravali Veeramachaneni, Alvia Moid, Charles P Barsano, Raghda Al Anbari, Nadiia Marenych, Sabah Patel, Boby George Theckedath
Publikováno v:
Journal of the Endocrine Society
We have previously reported that there is a strong association between unnecessarily ordered thyroid USGs and unnecessarily requested Endocrinology (Endo) consultations. Unnecessary consults consume time and resources, delay appropriate consults, and
Autor:
Ravali Veeramachaneni, Charles P Barsano, Karen Carvajal, Swetha Paduri, Mahwash Fatima Siddiqui, Raghda Al Anbari, Amna Elahi, Sabah Patel, Isha Shrestha
Publikováno v:
Journal of the Endocrine Society. 5:A869-A870
Though not a reliable indicator of malignancy, ultrasonic monitoring of nodule growth still has a role in the evaluation of nodules, e.g. indicating when a nodule may require biopsy or re-biopsy. Observer and technical limitations, however, limit the
Autor:
Mahwash Siddiqui, Ravali Veeramachaneni, Raghda Al Anbari, Karen Carvajal, Isha Shrestha, Charles P Barsano
Publikováno v:
Journal of the Endocrine Society
Nodule size is commonly referenced by the volume (Vol) of the nodule or by its longest dimension (LD), determined ultrasonically. Vol directly reflects the nodular mass in that a doubling (100% increase) of the nodular mass, for example, manifests as
Publikováno v:
Journal of the Endocrine Society
A commonly advocated TSH target range for guiding the dosage of thyroid hormone (L-T4) replacement in primary hypothyroidism is 0.3 to 3.0 mU/L. This is based on the physiological acceptability of individual TSH levels within this range. Individual s